← Open Payments lookup

SARA MESSIER: Open Payments

NPI 1831719566 · SUMTER, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$860 in 48 payments from 11 companies in 2025. Trend: 2023 $16 · 2024 $217 · 2025 $860

Food & beverage: $860
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.10$225
Teva Pharmaceuticals USA, Inc.13$224
ABBVIE INC.12$150
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$63
Alkermes, Inc.3$61
Vanda Pharmaceuticals Inc.2$42
Lundbeck LLC1$22
E.R. Squibb & Sons, L.L.C.1$20
Indivior Inc.1$19
Otsuka America Pharmaceutical, Inc.1$18

Products named: INGREZZA, AUSTEDO XR, VRAYLAR, UZEDY, CAPLYTA, ARISTADA, HETLIOZ, REXULTI.

Industry payments across SC — which companies pay providers there.